55 results about "Infusion therapy" patented technology

The present invention relates to delivery containers designed to deliver fluids for infusion to patients in a predetermined sequence, and methods for their construction and use. The containers described herein integrally comprise a plurality of non-fluidly connected chambers. The containers may be configured to deliver a volume of each medication of an infusion therapy in a predetermined sequence, duration, and / or interval from these chambers; alternatively, a container may be part of a larger device that provides the necessary hardware to perform such predetermined delivery. The container provides improved infusion therapy administration by reducing opportunities for error, infection, adverse drug interactions, or other complications.

A device, system and method are provided for controlling the rate of infusion of fluids during infusion therapy using non-electric infusion devices. Rotation of a flow regulator dial causes an orifice connected to the inlet to modify its position relative to a particular one or more orifices or groove portions, the characteristics of which provide a certain flow rate characteristic. The regulator allows for the infusion pump to infuse at a rate that may be varied during use by the user.

An infusion management system includes an infusion management server configured for providing an order to an infusion device to administer an infusion and the infusion device. The infusion device may be configured for receiving the order, associating the order with a patient, and adjusting at least one setting according to the order. A method for administering an infusion, an interface for an infusion device and a computer program product are also disclosed.

A site securement device for use in medical infusion therapy to selectively and temporarily retain a section of intravascular (IV) tube. The present device includes a unitary body with uniform or non-uniform channels for temporarily receiving and retaining a section of IV tubing in one or more channels, and may include an adhesive pad attached thereto for easy attachment to the skin of a patient.

An intravenous identification luminaire (IV-ID) and light pipe, and a light conductive intravenous delivery system is described. The light pipe preferably includes a female and male luer fitting, a fluid port, and a light source socket such that the light pipe is configured to be spliced into an IV line, and the IV-ID is coupled to the light pipe. The light pipe allows normal flow of the prescribed fluid through the light pipe while conducting light from the IV-ID, through the light source socket and along a conductive light path. The conductive light path continues into the IV line. The system also includes an indicator panel at the distal end of the IV line configured to reflect and make obvious the color of that particular IV line to a user.

The present invention extends to a disinfection cap for disinfecting a male luer end of an infusion therapy device. The disinfection cap can include an internal reservoir containing an antimicrobial or saline solution which is sealed with a flexible septum to prevent the solution from evaporating. The septum can include one or more slits or pierceable seams that allow a male luer end of an infusion therapy device to be inserted through the septum and into the solution. While the male luer is inserted through the septum, the solution contacts both the inner and outer surfaces of the male luer. Because the septum reduces evaporation of the solution and prevents the solution from leaking out of the cap, the solution remains in contact with the male luer for a longer duration then when typical disinfection caps are used thereby increasing the effectiveness of the disinfectant.

Decades of investigations were focused on finding “gold standard” for evaluation of plasma dilution and osmolality, blood loss evaluation and prediction of bleeding or transfusion induced changes in hematocrit and hemoglobin concentration. Addressing deficiencies of existing methods, the current invention created new combined mathematical-physiological model applicable to manually operated nomograms and software in medical monitors. The mathematical model HBS Trends is used in blood transfusion and infusion therapy nomogram—HBS Nomogram—which is based on blood hemoglobin concentration and hematocrit. It is also an easy and practical tool for recording and dynamical interpretation of plasma osmolality, blood hemoglobin concentration, hematocrit and mean corpuscular hemoglobin concentration. The HBS Nomogram is a practical system for organizing blood test results in a patient's medical records. It can be used alone or, in line with existing guidelines for infusion and transfusion therapy making them more practical, cost effective and time saving in decision making.

The present invention extends to a disinfection cap for disinfecting a male luer end of an infusion therapy device. The disinfection cap can include an internal reservoir containing an antimicrobial or saline solution which is sealed with a flexible septum to prevent the solution from evaporating. The septum can include one or more slits or pierceable seams that allow a male luer end of an infusion therapy device to be inserted through the septum and into the solution. While the male luer is inserted through the septum, the solution contacts both the inner and outer surfaces of the male luer. Because the septum reduces evaporation of the solution and prevents the solution from leaking out of the cap, the solution remains in contact with the male luer for a longer duration then when typical disinfection caps are used thereby increasing the effectiveness of the disinfectant.

An automatic pump relay system includes controllers coupled to drivers for sequentially discharging fluid from a plurality of medication containers into a coupler having a reflux barrier from which fluid is administered to a patient. The internal fluid pressure of the coupler is determined by a pressure sensing device or devices that provide signals to the controllers that, based at least on the sensor signals, cause the drivers to operate in reverse and forward directions so as to rapidly decrease and raise the fluid pressure within the coupler during a relay from an empty syringe to a filled syringe, thereby avoiding bolus formation and an interruption in infusion therapy. Independently operable syringes pumps are contemplated to be connected in relay fashion to form a modular system. An associated method is also disclosed wherein a fluid administration pressure is stored for use as a reference during a syringe changeover.

The present invention is a flow metering system for accurately metering and regulating the flow rate of fluid in a gravity fed intravenous fluid delivery system. The fluid flow is directed through a flow path guide that is suspended at an angle from one end. As the fluid flows through the flow path guide, the flow path guide bends due to the weight of the fluid. A drop of fluid forms at the end of the flow path guide then falls off, thereby releasing the flow path guide, which springs back it its original position. The sequence of drops and springing back continues throughout the fluid delivery procedure, and is monitored by sensors. The resultant data is used by a processor to determine the flow rate of the fluid. The flow rate may be adjusted as needed by a flow regulator that is responsive to an adjustment actuator that is controlled by the processor.

An infusion management system includes an infusion management server configured for providing an order to an infusion device to administer an infusion and the infusion device. The infusion device may be configured for receiving the order, associating the order with a patient, and adjusting at least one setting according to the order. A method for administering an infusion, an interface for an infusion device and a computer program product are also disclosed.

To provide infusion therapy that can effectively transluminally deliver drugs or the like to a target spot without invading areas other than a diseased area. The infusion therapy is for administering a drug, cells or the like, or inserting a treatment instrument into the target diseased area. A blood vessel area including a bifurcated blood vessel connecting to the diseased area is occluded at the distal and the proximal region thereof to form an occluded area, and the drugs or the like are pumped and supplied to the occluded area, which causes the drugs or the like to flow retrogressively and retentively in the bifurcated blood vessel connecting in the occluded area, and be infused and administered to the diseased area.

The present invention relates to delivery containers designed to deliver fluids for infusion to patients in a predetermined sequence, and methods for their construction and use. The containers described herein integrally comprise a plurality of non-fluidly connected chambers. The containers may be configured to deliver a volume of each medication of an infusion therapy in a predetermined sequence, duration, and / or interval from these chambers; alternatively, a container may be part of a larger device that provides the necessary hardware to perform such predetermined delivery. The container provides improved infusion therapy administration by reducing opportunities for error, infection, adverse drug interactions, or other complications.

To provide infusion therapy that can effectively transluminally deliver drugs or the like to a target spot without invading areas other than a diseased area. The infusion therapy is for administering a drug, cells or the like, or inserting a treatment instrument into the target diseased area. A blood vessel area including a bifurcated blood vessel connecting to the diseased area is occluded at the distal and the proximal region thereof to form an occluded area, and the drugs or the like are pumped and supplied to the occluded area, which causes the drugs or the like to flow retrogressively and retentively in the bifurcated blood vessel connecting in the occluded area, and be infused and administered to the diseased area.

An infusate cassette is described for use with an IV infusion system which controls the process of administering a drug to a patient. The cassette and other aspects of the infusion system may include disposable components, external redundant volume tracking, air removal and automated purge and prime capabilities, component removal lockout mechanisms, and / or redundant automated anti-free flow devices. An IV manifold comprising an imbedded high cracking pressure anti-free flow valve is also described for use with the infusion system. The cassette, IV manifold, and other aspects of the infusion system may be provided with quality assurance mechanisms for use with integrated IV infusion.

Disclosed is a method for infusion therapy management and recording medium which records the method in mobile device readable application, which controls fluid flow rate of the fluid set with acoustic output on a cycle of dropping rate corresponding to condition for injection of drug to be mixed in the fluid by inputting the condition as prescription for infusion therapy, registers management items by the patient, manages many patients under infusion therapy using one mobile device with knowledge of the present condition of infusion and infusion ending point, and controls the entire process of fluid infusion by modifying the condition of fluid infusion during the infusion

To provide a technique relating to a therapy for an immune-checkpoint inhibitor-resistant tumor. The problem can be solved by a pharmaceutical composition which is intended to be administered prior tothe administration of T cells specific to an antigen in a T cell infusion therapy for an immune-checkpoint inhibitor-resistant tumor, said pharmaceutical composition containing an antigen-encapsulated nano gel, wherein the antigen-encapsulated nano gel comprises a long-chain peptide antigen or a protein antigen each of which is encapsulated in a hydrophobized polysaccharide nano gel, and the long-chain peptide antigen or the protein antigen contains a CD8-positive cytotoxic T cell-recognizing epitope and a CD4-positive helper T cell-recognizing epitope both originated from the aforementionedantigen.

A device, system and method are provided for controlling the rate of infusion of fluids during infusion therapy using non-electric infusion devices. Rotation of a flow regulator dial causes an orifice connected to the inlet to modify its position relative to a particular one or more orifices or groove portions, the characteristics of which provide a certain flow rate characteristic. The flow regulator allows for the infusion pump to infuse at a rate that may be varied during use by the user. Additionally, the flow regulator is made from a material selected to operate under a wide range of pressures, from 5-40 PSI, making the flow regulator compatible with pressurized devices, such as, a non-electric pump.

The invention relates to cervical vertebra and lumbar vertebra massaging and nursing integrated equipment for surgical department. The equipment comprises a walking supporting device, a pushing suction device and a rotary manipulator device, wherein the pushing suction device is arranged on the lower end face of the top of the walking supporting device; the rotary manipulator device is arranged atthe left side of the pushing suction device; and the rotary manipulator device is arranged on the walking supporting device. With the application of the equipment provided by the invention, problemsof manual physiotherapy that high manual labor is consumed, vessels having special appearances cannot be fetched conveniently, infusion cannot be implemented in a physiotherapy process, medical articles needs to be reciprocally fetched by manpower, acupoint injection on human body is implemented by manpower and the like can be solved; the equipment can conduct automatic physiotherapy on the humanbody, and the equipment also has a function of implementing infusion in the physiotherapy process; and the equipment has the advantages that low manual labor is required, the vessels having special appearances can be sucked, infusion can be implemented in the physiotherapy process, the medical articles can be directly fetched from a medicine box, the acupoint injection on the human body can be automatically controlled and the like.

A mixing device and methods of utilizing the same. More specifically, embodiments of the present disclosure relate to a mixing device that may be used to make medications and specialized pharmaceuticals for administration via intrathecal infusion therapy, or the like. A mixing device may comprise an upper chamber, a lower chamber having four compartments for accepting an amount of medication, wherein the upper chamber and the lower chamber may be coupled and may be used to mix and make medication accessible via a Luer Lock adapter, termination, or the like, wherein the device is in compliance with USP 797 standards.

An electric multi-bottle infusion apparatus provided with a medicine-changing valve (9), an electric pushrod (10), and a controller (11). When a patient needs multiple medicinal solutions for an infusion therapy, a nurse connects multiple medicinal solution bottles (31) to the medicine-changing valve (9). When the medicinal solution of the first medicinal solution bottle (31) is depleted, either the patient or an accompanying person utilizes a remote control (30) of the controller (11) to control a pushrod valve core (14) of the electric pushrod (10) into moving, utilizes a solution-guiding hole (19) of the valve core (14) to connect the medicinal solution of the next medicinal solution bottle (31) to a solution-infusing apparatus (1), and utilizes the solution-infusing apparatus (1) for infusion of the patient. Such operation is repeated until the medicinal solution of the last medicinal solution bottle (31) is connected to the solution-infusing apparatus (1), thus solving the problem of nurse shortage.

According to an aspect of the present disclosure, a pump system for individualized healthcare use includes an infusion pump, a display, an input interface, and a pump controller. The pump controller is associated with a memory in which a closed set of predefined infusion therapies and a personalized identifier associated with an individual patient are stored. The pump controller is programmed to display the personalized identifier; to operate according to a first operational state, wherein the pump controller receives an input via the input interface, selects a predefined infusion therapy according to the input received, and controls the infusion pump to provide the selected predefined infusion therapy; to operate according to a second operational state; and to receive an operational state code via the input interface, and to change from the first to the second operational state only when the operational state code is received.

A mixing device and methods of utilizing the same. More specifically, embodiments of the present disclosure relate to a mixing device that may be used to make medications and specialized pharmaceuticals for administration via intrathecal infusion therapy, or the like. A mixing device may comprise an upper chamber, a lower chamber having four compartments for accepting an amount of medication, wherein the upper chamber and the lower chamber may be coupled and may be used to mix and make medication accessible via a Luer Lock adapter, termination, or the like, wherein the device is in compliance with USP 797 standards.

The present invention relates to an infusion flow adjuster which is used in order to adjust the flow rate of an infusion solution to be administered when performing infusion therapy, and relates to an infusion flow adjuster in which an arc-shaped flow path for adjusting the distance through which the infusion solution passes and a circular flow path for inducing discharge of the infusion solution that has passed through the arc-shaped flow path are constituted in a single plane, and which is easy to produce as a product for accurately adjusting the flow rate, affords convenience of handling being provided with a handle in a suitable position, and also, in addition to allowing fine adjustment of the flow rate, limits the maximum flow rate to an appropriate value, so being convenient to use during actual infusion therapy.

An antigen-loaded nanogel is formed by loading or encapsulating one or more long peptide antigens or one or more protein antigens in a hydrophobized polysaccharide. The long peptide antigen(s) or protein antigen(s) contains (or each contain) one or more CD8+ cytotoxic T cell recognition epitopes and / or one or more CD4+ helper T cell recognition epitopes, which is / are derived from the antigen. The antigen-loaded nanogel may be administered prior to administration of antigen-specific T cells to improve the efficacy of a T cell infusion therapy against an immune checkpoint inhibitor-resistant tumor. The hydrophobized polysaccharide may be pullulan having cholesteryl groups bound thereto. An immune-enhancing agent also may be administered in or with the antigen-loaded nanogel.

The invention discloses a neurologic nursing bed which comprises a bedstead. The bedstead comprises cylindrical bed frames, a sleeve is arranged on the outer side of each of the left and right bed frames, a first locking screw used for fixing the corresponding sleeve to each bed frame is arranged on the outer wall of each sleeve, a fixed plate is arranged on the outer wall of each sleeve and arranged in a manner of being perpendicular to the edge of one end of the sleeve, a rotating plate is arranged on one side of each sleeve, a first open groove in left-right communication is formed in one end of each rotating plate, the end of each fixed plate is positioned in the corresponding first open groove, a first through hole penetrating the corresponding fixed plate is formed in each rotating plate, and a second locking screw used for fixing the corresponding fixed plate to the corresponding rotating plate is arranged in the first through hole; a connecting plate is arranged on one side, away from the corresponding first open groove, of each rotating plate, a first open groove in up-down communication is formed in the end of each connecting plate, and one end, away from the corresponding fixed plate, of each rotating plate is positioned in the corresponding second open groove. The neurologic nursing bed brings convenience to infusion of carotic or paralyzed patients and can avoid influence of some non-autonomous reflective actions of patients on infusion treatment.

A portable intravenous bag positive pressure device includes a main body and an elastic positioning unit. The main body is to encircle the arm of a patient at an appropriate position with its adjustable positioning belt to secure the main body. An intravenous bag is placed into an accommodation space formed between a positioning seat of the main body and the elastic positioning unit. The elastic positioning unit applies positive pressure to the intravenous bag to continuously output an infusion liquid for infusion therapy. The device has a simple structure and is convenient for wearing and able to secure the intravenous bag firmly on the arm of the patient. It is beneficial for the patient to carry the intravenous bag and move around during infusion therapy.